7. 2 major mechanisms:
- Loss of TP53 function
-overexpression of apoptotic members
of BCL2 family
8. Loss of TP53 function:
Frequency of TP53 mutation higher in tumours
Lesions in Cancer impair P53
Amplification of MDM2( inhibitor of P53)
Prevent unregulation of PUMA( pro-apoptopic
BH3 - only protein)
Allowing cells to survive
9. Over expression of BCL2:
Protection of tumour cells from
apoptosis.
Eg: B cell lymphoma ( due to
translocation)
Also for cancer cell survival and drug
resistance.